NewcelX Ltd. SEC filings NCEL
NewcelX Ltd. has 417 filings in SEC EDGAR's recent list, going back to Dec 18, 2019. Its latest annual report, Form 20-F, was filed on Apr 29, 2026 for the period ended Dec 31, 2025. The most recent current report (Form 6-K) was filed on Nov 4, 2026. The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| EFFECT | Filing | Sep 22, 2026 | — |
| EFFECT | Filing | Aug 26, 2026 | — |
| D | Filing | Aug 24, 2026 | — |
| EFFECT | Filing | Jun 17, 2026 | — |
| EFFECT | Filing | May 15, 2026 | — |
| UPLOAD | Letter from the SEC | May 14, 2026 | — |
| CORRESP | Letter to the SEC | May 14, 2026 | — |
| D | Filing | May 13, 2026 | — |
| EFFECT | Filing | May 6, 2026 | — |
| EFFECT | Filing | Nov 18, 2025 | — |
| EFFECT | Filing | Nov 18, 2025 | — |
| 25-NSE/A | Filing | Oct 30, 2025 | — |
| EFFECT | Filing | Sep 30, 2025 | — |
| CORRESP | Letter to the SEC | Sep 29, 2025 | — |
| UPLOAD | Letter from the SEC | Sep 29, 2025 | — |
| EFFECT | Filing | Sep 9, 2025 | — |
| CORRESP | Letter to the SEC | Sep 8, 2025 | — |
| 425 | Form 425 | Sep 4, 2025 | — |
| CORRESP | Letter to the SEC | Sep 3, 2025 | — |
| 425 | Form 425 | Aug 29, 2025 | — |
| UPLOAD | Letter from the SEC | Aug 28, 2025 | — |
| CORRESP | Letter to the SEC | Aug 15, 2025 | — |
| UPLOAD | Letter from the SEC | Aug 6, 2025 | — |
| CORRESP | Letter to the SEC | Jul 29, 2025 | — |
| UPLOAD | Letter from the SEC | Jul 23, 2025 | — |
| 425 | Form 425 | Jul 18, 2025 | — |
| D | Filing | Jul 10, 2025 | — |
| 425 | Form 425 | Jul 1, 2025 | — |
| CORRESP | Letter to the SEC | Jun 23, 2025 | — |
| UPLOAD | Letter from the SEC | Jun 18, 2025 | — |
| 425 | Form 425 | Jun 16, 2025 | — |
| CORRESP | Letter to the SEC | Jun 9, 2025 | — |
| CORRESP | Letter to the SEC | Jun 9, 2025 | — |
| 425 | Form 425 | Jun 6, 2025 | — |
| NT 20-F | Notification of late filing | May 1, 2025 | Dec 31, 2024 |
| UPLOAD | Letter from the SEC | Apr 15, 2025 | — |
| 425 | Form 425 | Apr 15, 2025 | — |
| D | Filing | Apr 14, 2025 | — |
| CORRESP | Letter to the SEC | Mar 31, 2025 | — |
| 425 | Form 425 | Mar 31, 2025 | — |
| UPLOAD | Letter from the SEC | Mar 20, 2025 | — |
| 425 | Form 425 | Mar 10, 2025 | — |
| CORRESP | Letter to the SEC | Feb 28, 2025 | — |
| 425 | Form 425 | Feb 25, 2025 | — |
| 425 | Form 425 | Feb 10, 2025 | — |
| 425 | Form 425 | Jan 31, 2025 | — |
| 425 | Form 425 | Jan 28, 2025 | — |
| UPLOAD | Letter from the SEC | Jan 27, 2025 | — |
| D | Filing | Jan 22, 2025 | — |
| 425 | Form 425 | Jan 16, 2025 | — |
| 425 | Form 425 | Jan 8, 2025 | — |
| 425 | Form 425 | Dec 30, 2024 | — |
| 425 | Form 425 | Dec 19, 2024 | — |
| 425 | Form 425 | Dec 11, 2024 | — |
| EFFECT | Filing | Nov 26, 2024 | — |
| CORRESP | Letter to the SEC | Nov 25, 2024 | — |
| CORRESP | Letter to the SEC | Nov 18, 2024 | — |
| 425 | Form 425 | Nov 5, 2024 | — |
| 425 | Form 425 | Nov 4, 2024 | — |
| UPLOAD | Letter from the SEC | Nov 1, 2024 | — |
| D | Filing | Oct 21, 2024 | — |
| D | Filing | Jul 15, 2024 | — |
| EFFECT | Filing | Jun 25, 2024 | — |
| CORRESP | Letter to the SEC | Jun 24, 2024 | — |
| UPLOAD | Letter from the SEC | May 31, 2024 | — |
| NT 20-F | Notification of late filing | Apr 30, 2024 | Dec 31, 2023 |
| D | Filing | Apr 3, 2024 | — |
| NT 20-F | Notification of late filing | May 1, 2023 | Dec 31, 2022 |
| EFFECT | Filing | Jan 20, 2023 | — |
| CORRESP | Letter to the SEC | Jan 18, 2023 | — |
| UPLOAD | Letter from the SEC | Jan 18, 2023 | — |
| D | Filing | Dec 21, 2022 | — |
| EFFECT | Filing | Dec 15, 2022 | — |
| CORRESP | Letter to the SEC | Dec 13, 2022 | — |
| UPLOAD | Letter from the SEC | Dec 13, 2022 | — |
| D | Filing | Oct 14, 2022 | — |
| EFFECT | Filing | Jun 21, 2022 | — |
| CORRESP | Letter to the SEC | Jun 17, 2022 | — |
| UPLOAD | Letter from the SEC | Jun 16, 2022 | — |
| EFFECT | Filing | Feb 11, 2022 | — |
| CORRESP | Letter to the SEC | Feb 10, 2022 | — |
| UPLOAD | Letter from the SEC | Feb 8, 2022 | — |
| EFFECT | Filing | Jan 6, 2022 | — |
| CORRESP | Letter to the SEC | Jan 4, 2022 | — |
| UPLOAD | Letter from the SEC | Jan 4, 2022 | — |
| EFFECT | Filing | Nov 3, 2021 | — |
| CORRESP | Letter to the SEC | Nov 1, 2021 | — |
| UPLOAD | Letter from the SEC | Oct 28, 2021 | — |
| EFFECT | Filing | Oct 1, 2021 | — |
| EFFECT | Filing | Jun 4, 2021 | — |
| NT 20-F | Notification of late filing | Apr 30, 2021 | Dec 31, 2020 |
| POS EX | Filing | Feb 2, 2021 | — |
| EFFECT | Filing | Jan 28, 2021 | — |
| CERT | Filing | Jan 28, 2021 | — |
| CERT | Filing | Jan 28, 2021 | — |
| 8-A12B | Filing | Jan 28, 2021 | — |
| CORRESP | Letter to the SEC | Jan 25, 2021 | — |
| CORRESP | Letter to the SEC | Jan 25, 2021 | — |
| CORRESP | Letter to the SEC | Nov 19, 2020 | — |
| UPLOAD | Letter from the SEC | Nov 17, 2020 | — |
| CORRESP | Letter to the SEC | Oct 19, 2020 | — |
| UPLOAD | Letter from the SEC | Sep 17, 2020 | — |
| CORRESP | Letter to the SEC | Aug 31, 2020 | — |
| UPLOAD | Letter from the SEC | Mar 3, 2020 | — |
| DRSLTR | Filing | Feb 20, 2020 | — |
| DRS/A | Filing | Feb 20, 2020 | — |
| UPLOAD | Letter from the SEC | Jan 15, 2020 | — |
| DRS | Filing | Dec 18, 2019 | — |
Showing 108 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- NCEL (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- Switzerland
- Headquarters
- Zurich
- SEC filer status
- Non-accelerated filer, Emerging growth company
- SEC CIK
- 1783036
- Former names
- NLS Pharmaceutics Ltd. (until Oct 30, 2025)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.